PowerUp Acquisition Corporation (PWUP) News

PowerUp will hold an extraordinary general meeting..... to consider matters relating to the Business Combination at 9:00 AM, Eastern Time, on February 4, 2025.

Proposal No. 1 — The Business Combination Proposal —

PowerUp has unanimously approved the Business Combination Agreement and the transactions contemplated thereby, including the Business Combination and PowerUp Domestication, and unanimously recommends that shareholders vote “FOR” the adoption of the Business Combination Agreement and approval of the transactions contemplated thereby, including the Business Combination and PowerUp Domestication, and “FOR” all other proposals presented to PowerUp’s shareholders in the proxy statement/prospectus.

424B3
01/14/2025
https://www.otcmarkets.com/filing/html?id=18106839&guid=3D0-kKRdcsFTh3h

oops

Aspire Pharma acquires Canute to expand strategic portfolio

7 October 2024
https://pharmaceuticalmanufacturer.media/pharma-manufacturing-news/latest-pharmaceutical-manufacturing-news/aspire-pharma-acquires-canute-to-expand%C2%A0strategic-portfolio/

About the Company

https://aspirebiolabs.com/about/

I dont know if this is the merging company...

Aspire Biopharma, Inc., and PowerUp Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-listed Biopharmaceutical Company Driving Breakthrough Innovations in FDA Approved Drugs, Nutraceuticals and Supplements

September 03, 2024
https://www.globenewswire.com/news-release/2024/09/03/2939657/0/en/Aspire-Biopharma-Inc-and-PowerUp-Acquisition-Corp-Announce-Business-Combination-Agreement-to-Create-Nasdaq-listed-Biopharmaceutical-Company-Driving-Breakthrough-Innovations-in-FDA-.html

Aspire Overview

Aspire Biopharma, Inc. is a privately held, early-stage biopharmaceutical technology company founded in 2021. The Company is engaged in the business of developing and marketing a disruptive technology for novel delivery mechanisms for “do no harm” FDA approved drugs, nutraceuticals and supplements. Aspire has developed and acquired technologies that are a Novel Soluble Formulation which address emergencies and drug efficacy, dosage management, patient compliance and safety and rapid response and absorption time when required and desired.